Evaluation of Instruments and Procedures Used to... — Clinical Trial Details

The objective of this study is to evaluate the instruments and procedures to be used in a subsequent study of the
safety and tolerability of noribogaine in opioid dependent Participants. In particular, this study will evaluate the
ability of various assessment scales to detect the signs and symptoms of opioid withdrawal in the study
population.

The main inclusion criteria are opioid dependent male and female adults (18-55 years) who provide written consent and are on stable doses of methadone through the OST programme. Participants cannot have any other major illnesses or disorders and must be willing to comply with the restrictions of the study.

Exclusion criteria include current treatment for hepatitis C; HIV positive; DSM IV Axis I diagnosis of psychotic disorders; specified excluded concomitant medications; DSM IV criteria for dependence on substances other than opioids, caffeine, and/or nicotine.

Unknown facility — Australia

Start: 2013-07-30

End: 2013-08-09

Company

Product

Legal

Detailed Description

Study Arms & Interventions

Experimental Arm

Participants

Inclusion Criteria

Exclusion Criteria

Locations

Study Details